5,000
Participants
Start Date
April 2, 2020
Primary Completion Date
May 26, 2022
Study Completion Date
May 26, 2022
therascreen® KRAS RGQ PCR Kit
The KRAS Kit is a real-time qualitative PCR assay used on the Rotor-Gene Q MDx instrument for the detection of somatic G12C mutations in the human KRAS oncogene using DNA extracted from formalin fixed paraffin-embedded (FFPE) Non-small Cell Lung Cancer (NSCLC) tissue.
QIAGEN Gaithersburg, Inc, Manchester
Collaborators (1)
Amgen
INDUSTRY
QIAGEN Gaithersburg, Inc
INDUSTRY